COST-EFFECTIVENESS OF IN-DEVELOPMENT AND HYPOTHETICAL PNEUMOCOCCAL CONJUGATE VACCINES IN ADULTS AGED ≥65 YEARS: AN EXPLORATORY ANALYSIS

被引：0
|
作者：
Smith, Kenneth J. [1 ]
Wateska, Angela [1 ]
Nowalk, Mary Patricia [2 ]
Lin, Chyongchiou J. [3 ]
Zimmerman, Richard K. [2 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Family Med, Pittsburgh, PA USA
[3] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA
来源：
MEDICAL DECISION MAKING | 2021年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：E242 / E243
页数：2
相关论文
共 50 条
  • [1] Cost-Effectiveness of Pneumococcal Vaccines for Adults Aged 65 Years and Older in Argentina
    Giglio, Norberto D.
    Castellano, Vanesa E.
    Mizrahi, Patricia
    Micone, Paula, V
    VALUE IN HEALTH REGIONAL ISSUES, 2022, 28 : 76 - 81
  • [2] Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study
    Guo, Jia
    Zhang, Haijun
    Zhang, Haonan
    Lai, Xiaozhen
    Wang, Jiahao
    Feng, Huangyufei
    Fang, Hai
    VACCINE, 2023, 41 (03) : 716 - 723
  • [3] Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older
    Altawalbeh, Shoroq M.
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    VACCINE, 2024, 42 (12) : 3024 - 3032
  • [4] COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINATION STRATEGIES IN US ADULTS AGED 65 AND OLDER
    Smith, Kenneth J.
    Wateska, Angela
    Nowalk, Mary Patricia
    Raymund, Mahlon
    Zimmerman, Richard K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S150 - S150
  • [5] Higher-Valency Pneumococcal Conjugate Vaccines: An Exploratory Cost-Effectiveness Analysis in US Seniors
    Smith, Kenneth J.
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 61 (01) : 28 - 36
  • [6] Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan
    Nakamura, Shigeki
    Mikami, Masashi
    Hayamizu, Tomoyuki
    Yonemoto, Naohiro
    Moyon, Camille
    Gouldson, Mark
    Crossan, Catriona
    Vietri, Jeffrey
    Kamei, Kazumasa
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 546 - 560
  • [7] Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in US Populations
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2020, 58 (04) : 487 - 495
  • [8] Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    VACCINE, 2023, 41 (30) : 4431 - 4437
  • [9] A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia
    Ordonez, Jaime E. E.
    Ordonez, Angelica
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 216 - 225
  • [10] Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults
    Smith, Kenneth J.
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Zimmerman, Richard K.
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP80 - NP82
12345